Relevant bibliographies by topics / Prognosis e recurrence

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Prognosis e recurrence'

Author: Grafiati
Published: 4 June 2021
Last updated: 14 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Prognosis e recurrence.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Prognosis e recurrence"

1

Sako, Keisuke, Kengo Furuichi, Yuta Yamamura, et al. "Association between the recurrence period of acute kidney injury and mortality: a single-centre retrospective observational study in Japan." BMJ Open 9, no. 6 (2019): e023259. http://dx.doi.org/10.1136/bmjopen-2018-023259.

Full text
Abstract:
ObjectivesRecurrent acute kidney injury (AKI) is a recognised risk factor for mortality. However, it is unclear whether the period until AKI recurrence may have a major factor on patient outcome or not. To explore this issue, we (1) framed the hypothesis that early recurrence increases the risk of mortality and (2) evaluated the prognosis of recurrent AKI cases by setting 21 days as the cut-off period.MethodsAll studied cases were admitted and followed up at the Kanazawa University Hospital (Kanazawa, Japan) between 1 November 2006 and 31 October 2007. In total, 21 939 patients were retrospect
APA, Harvard, Vancouver, ISO, and other styles
2

Davydova, Irina, Apollon Karseladze, Viktor Kuznetsov, and Liudmila Meshcheriakova. "Surgical treatment of recurrent borderline serous ovarian tumor." Problems in oncology 67, no. 4 (2021): 538–46. http://dx.doi.org/10.37469/0507-3758-2021-67-4-538-546.

Full text
Abstract:
Recurrences of serous borderline tumors (PCOS) are quite rare and, as a result, have not been sufficiently studied and presented in the literature. Despite the obvious relative «benignity» of borderline tumors, the course and prognosis of recurrent PCOS may be unfavorable. The article describes the reasons influencing the development of recurrence of PCOS, presents various options for recurrence of PCOS, methods of their treatment. This publication highlights the factors influencing the effectiveness of treatment, survival and prognosis of the disease. The article is illustrated with a rare cl
APA, Harvard, Vancouver, ISO, and other styles
3

Osako, T., R. Nishimura, Y. Okumura, R. Tashima, Y. Toyozumi, and N. Arima. "Survival after locoregional recurrence in patients after breast cancer surgery." Journal of Clinical Oncology 29, no. 27_suppl (2011): 141. http://dx.doi.org/10.1200/jco.2011.29.27_suppl.141.

Full text
Abstract:
141 Background: The purpose of this study was to investigate factors for survival after locoregional recurrence in patients who underwent mastectomy or breast-conserving therapy (BCT) for primary breast cancer in our hospital. Methods: Out of 3,332 patients operated on from 1989 to 2008, 50 patients had chest wall recurrences after mastectomy (CWR), 40 patients had regional nodal recurrences (RNR), and 24 patients had ipsilateral breast tumor recurrences (IBTR) from 1997 to 2008. To investigate the prognostic factors for survival after locoregional recurrence, we conducted uni- and multivariat
APA, Harvard, Vancouver, ISO, and other styles
4

Gronchi, A., P. G. Casali, L. Mariani, et al. "Quality of Surgery and Outcome in Extra-Abdominal Aggressive Fibromatosis: A Series of Patients Surgically Treated at a Single Institution." Journal of Clinical Oncology 21, no. 7 (2003): 1390–97. http://dx.doi.org/10.1200/jco.2003.05.150.

Full text
Abstract:
Purpose: To explore prognostic factors in surgically treated aggressive fibromatosis (extra-abdominal desmoid tumor). Patients and Methods: A total of 203 consecutive patients treated with surgery over a 35-year period at a single referral center were retrospectively reviewed. One hundred twenty-eight were first seen at our institution with primary disease, whereas 75 had a recurrent tumor. All patients underwent macroscopically complete resection. Margins were rated as negative in 146 (97 with primary tumors, 49 with recurrences) and positive in 57 (31 in primary, 26 in recurrences) patients.
APA, Harvard, Vancouver, ISO, and other styles
5

Ma, Hui, Zhongchen Li, Jia Yuan, et al. "Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation." Gastroenterology Research and Practice 2021 (January 2, 2021): 1–7. http://dx.doi.org/10.1155/2021/8878417.

Full text
Abstract:
Objective. Recurrence after curative resection for hepatocellular carcinoma (HCC) is a major cause of death from this disease. Factors of primary curative resection are available and potential in the prognosis of follow-up treatment. Our aim was to assess the prognostic significance of primary curative resection factors in recurrent HCC patients undergoing radiofrequency ablation therapy (RFA). Methods. In this retrospective study, we assessed 235 patients who underwent limited RFA of HCC recurrences ( tumors ≤ 5 cm ; nodules ≤ 3 ) after primary curative resection. Factors of primary curative
APA, Harvard, Vancouver, ISO, and other styles
6

Nishiyama, Mitsuo, Shigeru Takeda, Shinsuke Kanekiyo, et al. "PS02.214: ANALYSIS OF PROGNOSTIC FACTORS IN RECURRENCE CASES AFTER SURGERY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA." Diseases of the Esophagus 31, Supplement_1 (2018): 182–83. http://dx.doi.org/10.1093/dote/doy089.ps02.214.

Full text
Abstract:
Abstract Background Esophageal cancer is one of the most malignant gastrointestinal cancers and prognosis in recurrent cases remains extremely poor. However some studies show a relatively favorable prognosis among patients with solitary recurrence site who undergo locoregional therapy. It is important to clarify prognostic factors in postrecurrence cases. Methods This study included 156 patients who underwent curative resection for esophageal squamous cell carcinoma from January 2005 to December 2014. In this retrospective study we analysed relationship between clinicopathologic factors and pr
APA, Harvard, Vancouver, ISO, and other styles
7

Li, Guangqi, Yuanjun Jiang, Xintong Lyu, et al. "Deconvolution and network analysis of IDH-mutant lower grade glioma predict recurrence and indicate therapeutic targets." Epigenomics 11, no. 11 (2019): 1323–33. http://dx.doi.org/10.2217/epi-2019-0137.

Full text
Abstract:
Aim: IDH-mutant lower grade glioma (LGG) has been proven to have a good prognosis. However, its high recurrence rate has become a major therapeutic difficulty. Materials & methods: We combined epigenomic deconvolution and a network analysis on The Cancer Genome Atlas IDH-mutant LGG data. Results: Cell type compositions between recurrent and primary gliomas are significantly different, and the key cell type that determines the prognosis and recurrence risk was identified. A scoring model consisting of four gene expression levels predicts the recurrence risk (area under the receiver operatin
APA, Harvard, Vancouver, ISO, and other styles
8

Chen, Yue, Rui Zhang, Xinxin Dong, and Fang Liu. "Evaluation of prognosis of rectal cancer patients with neoadjuvant chemoradiotherapy by clinical TNM stage: Is it suitable?" Journal of Clinical Oncology 38, no. 15_suppl (2020): e16029-e16029. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16029.

Full text
Abstract:
e16029 Background: In the Union for International Cancer Control /American Joint Committee on Cancer TNM classification system, the prognosis of rectal cancer patients with adjuvant treatment are based on pre-radiotherapy clinical TNM stage. However, the value of this classification system is still debated. Here, we find that neoadjuvant pathologic TNM stage may be better than clinical TNM stage in patients with rectal cancer. Furthermore, we propose a novel risk stratification which may be more accurate in the assessment of prognosis of these patients. Methods: Between 2010 and 2015, 316 pati
APA, Harvard, Vancouver, ISO, and other styles
9

Jud, Sebastian M., Reinhard Hatko, Julius Emons, et al. "Discordance between Primary Breast Cancer and Ipsilateral Breast Cancer Tumor Recurrence as a Function of Distance." Journal of Clinical Medicine 9, no. 12 (2020): 4033. http://dx.doi.org/10.3390/jcm9124033.

Full text
Abstract:
Background: Risk factors for ipsilateral breast cancer tumor recurrence (IBTR) are well established and include grading, nodal status, and receptor status. Little is known about the influence of the local distance between the primary tumor and recurrences on changes in tumor characteristics and prognosis. Methods: In a retrospective setting, we analyzed primary breast cancers and their recurrences. Localizations of primary and recurrent breast cancer were recorded to calculate the relative distance in pixels. Analysis was performed regarding tumor characteristics, relative distance between bot
APA, Harvard, Vancouver, ISO, and other styles
10

Ninomiya, Itasu, Koichi Okamoto, Katsunobu Oyama, Jun Kinoshita, Sachio Fushida, and Tetsuo Ohta. "FA06.04: SURVIVAL BENEFIT OF MULTIMODAL LOCAL THERAPY FOR REPEAT RECURRENCE OF THORACIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA AFTER THORACOSCOPIC ESOPHAGECTOMY." Diseases of the Esophagus 31, Supplement_1 (2018): 12. http://dx.doi.org/10.1093/dote/doy089.fa06.04.

Full text
Abstract:
Abstract Background This study was performed to clarify the optimal therapeutic strategy for recurrent disease after thoracoscopic esophagectomy (TE). We especially focused on the prognostic impact of multimodal local therapy for localized recurrence. Methods We investigated the prognosis of 49 patients who developed recurrence among 140 patients who underwent TE at Kanazawa University Hospital. The prognostic factors after recurrence were examined by univariate and multivariate analysis. Results The patterns of initial recurrence included hematological recurrence in 24 patients (17.1%), lymph
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Prognosis e recurrence"

1

Pennlert, Johanna. "Recurrent stroke : risk factors, predictors and prognosis." Doctoral thesis, Umeå universitet, Medicin, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-127304.

Full text
Abstract:
Background Many risk factors for stroke are well characterized and might, at least to some extent, be similar for first-ever stroke and for recurrent stroke events. However, previous studies have shown heterogeneous results on predictors and rates of stroke recurrence. Patients who survive spontaneous intracerebral hemorrhage (ICH) often have compelling indications for antithrombotic (AT) treatment (antiplatelet (AP) and/or anticoagulant (AC) treatment), but due to controversy of the decision to treat, a large proportion of these patients are untreated. In the absence of evidence from randomiz
APA, Harvard, Vancouver, ISO, and other styles
2

Durkan, Garrett Christopher. "Matrix metalloproteinase-1 and -9 and tissue inhibitor of metalloproteinase-1 in bladder cancer : pathophysiological significance and relationship to epidermal growth factor receptor expression." Thesis, University of Newcastle Upon Tyne, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.369832.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Leckey, Joan Lesley. "Urinary and tumour markers of disease recurrence and prognosis in transitional cell carcinoma of the bladder." Thesis, University of Ulster, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.310119.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Huhtakangas, J. (Juha). "The influence of medication on the incidence, outcome, and recurrence of primary intracerebral hemorrhage." Doctoral thesis, Oulun yliopisto, 2012. http://urn.fi/urn:isbn:9789514299438.

Full text
Abstract:
Abstract Intracerebral hemorrhage (ICH) is the most pernicious form of stroke, with high mortality. Warfarin-associated ICH (WA-ICH) carries an even higher mortality rate. The major reason for the high mortality is explained by early hematoma growth. Warfarin use has rapidly increased with the aging of the population. We investigated temporal trends in the incidence and outcome of WA-ICHs. We found that although the proportion of warfarin users almost quadrupled in our population, the annual incidence and case fatality of WA-ICHs decreased. Management of ICH is mostly supportive. Prevention of
APA, Harvard, Vancouver, ISO, and other styles
5

Teixeira, Roberto Augusto Plaza. ""Fatores clínicos e biológicos para recidivas em tumores de Wilms localizados"." Universidade de São Paulo, 2005. http://www.teses.usp.br/teses/disponiveis/5/5141/tde-04012006-105538/.

Full text
Abstract:
Apesar do excelente prognóstico dos tumores de Wilms (TW) localizados (estádios I e II) e de histologia favorável (HF), 10% deles recidivam. Em 122 pacientes com TW com essas características, diagnosticados de 1976 e 2001, analisamos alguns fatores clínicos, como a idade por ocasião do diagnóstico e peso do tumor, em todos os pacientes; fatores biológicos, como o TP53 e a glicoproteína-p, em 40 deles; e variáveis histológicas de microestadiamento (invasão de seio renal, cápsula tumoral, vasos intra-renais e pseudocápsula inflamatória) em 28 com TW em estádio I. Correlacionando todos esses fato
APA, Harvard, Vancouver, ISO, and other styles
6

Sena, Marina Fernandes de. "Recidiva de c?ncer labial em pacientes atendidos no Hospital Dr. Luiz Ant?nio (Natal-RN) entre 1997-2004." Universidade Federal do Rio Grande do Norte, 2009. http://repositorio.ufrn.br:8080/jspui/handle/123456789/17052.

Full text
Abstract:
Made available in DSpace on 2014-12-17T15:30:53Z (GMT). No. of bitstreams: 1 MarinaFS.pdf: 587515 bytes, checksum: 475e3de91c334287e77aaef918353e42 (MD5) Previous issue date: 2009-03-26<br>Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior<br>Introduction: Cancer of the lip is very common in tropical countries, being noticeable the squamous cell carcinoma as the main histological type. Objective: Evaluate the socialdemographic profile, habits, occupation, clinical characteristics of the cancer lesions and the aftermath of treatment of the patients treated on the Luiz Ant?nio Hospi
APA, Harvard, Vancouver, ISO, and other styles
7

Viana, Aline de Oliveira Ribeiro. "Expressão de marcadores moleculares preditivos de recorrência locoregional de carcinoma papilífero de tireoide." Universidade de São Paulo, 2019. http://www.teses.usp.br/teses/disponiveis/5/5155/tde-21032019-092957/.

Full text
Abstract:
INTRODUÇÃO: O carcinoma papilífero é o tumor maligno mais comum da tireoide e sua incidência vem aumentando em todo o mundo nas últimas décadas. A maioria dos pacientes com carcinoma papilífero apresenta bom prognóstico, com uma taxa de sobrevida em 10 anos de 90 a 95%, porém, as taxas de recorrência e a necessidade de continuar o tratamento continuam a ser um problema significativo para 5 a 40% dos pacientes. Embora sejam utilizadas diversas classificações de risco baseadas em diferentes fatores prognósticos, nenhuma é capaz de predizer quais pacientes terão maior chance de recorrência e desf
APA, Harvard, Vancouver, ISO, and other styles
8

Chagas, Aline Lopes. "Avaliação da recidiva do carcinoma hepatocelular em pacientes submetidos a transplante de fígado no Brasil." Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/5/5168/tde-30012018-121035/.

Full text
Abstract:
INTRODUÇÃO: O transplante (TX) de fígado corresponde ao tratamento de escolha em pacientes com cirrose e carcinoma hepatocelular (CHC) precoce irressecável. A recidiva do CHC pós-transplante, entretanto, ainda apresenta impacto na sobrevida dos pacientes transplantados com este tumor. As taxas de recidiva, nos estudos mais recentes, variam de 8 a 20%. O tamanho e número de nódulos, a presença de invasão vascular e de nódulos satélites no explante, são fatores de risco relacionados à recidiva tumoral pós-transplante. No Brasil, observamos um crescimento importante do número de transplantes de f
APA, Harvard, Vancouver, ISO, and other styles
9

Junior, Mituro Hattori. "Fatores prognósticos em carcinomas de glândulas salivares recidivados submetidos à cirurgia de resgate." Universidade de São Paulo, 2007. http://www.teses.usp.br/teses/disponiveis/5/5155/tde-13022008-105752/.

Full text
Abstract:
Carcinomas de glândulas salivares são raros e seu tratamento de escolha é cirúrgico, seguido ou não de radioterapia. Até 50% dos casos apresentam recorrências neoplásicas e a maioria delas é local. O único tratamento de resgate com potencial curativo é o cirúrgico. No entanto, poucos estudos abordam o tema. O objetivo deste estudo é avaliar a ocorrência de complicações cirúrgicas e os fatores prognósticos clínicos e anatomopatológicos em pacientes portadores de carcinoma de glândulas salivares recidivado, submetidos à cirurgia de resgate. Foram avaliados 59 pacientes que preenchiam os critério
APA, Harvard, Vancouver, ISO, and other styles
10

Vicente, Carolina de Jesus Pardal. "Avaliação de fatores de risco para a evolução clínica e prognóstico a curto e longo prazo de hérnias perineais : estudo retrospetivo em 75 animais da espécie Canis familiaris." Master's thesis, Universidade de Lisboa, Faculdade de Medicina Veterinária, 2018. http://hdl.handle.net/10400.5/16431.

Full text
Abstract:
Dissertação de Mestrado Integrado em Medicina Veterinária<br>Hérnia perineal é uma entidade clínica reconhecida em várias espécies, especialmente no cão macho não castrado de idade adulta a avançada, surgindo por enfraquecimento e separação dos componentes do diafragma pélvico, o que permite a passagem de estruturas entre eles. Pensa-se que se trate de uma entidade de etiologia multifatorial, tendo sido implicados diversos fatores: atrofia dos músculos do diafragma pélvico, alterações retais, desequilíbrios hormonais, excesso de pressão no diafragma pélvico e efeito da relaxina prostátic
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Prognosis e recurrence"

1

Leckey, Joan Lesley. Urinary and tumour markers of disease recurrence and prognosis in transitional cell carcinoma of the bladder. The Author], 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Naess, Halvor. Long-term prognosis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198722366.003.0016.

Full text
Abstract:
Knowledge of prognosis is important for patients in the prime of life in order to make informed decisions about treatment, choice of education, and profession. Median first-year mortality after first-ever cerebral infarction among young adults is about 4% while median annual average mortality after the first year is about 1.7%. Likewise, median first-year recurrence rate of cerebral infarction is 2% and thereafter 1.5% per year. Risk factors for recurrent cerebral infarction include hypertension, diabetes mellitus, symptomatic atherosclerosis, and smoking. Recurrent cerebral infarction and mor
APA, Harvard, Vancouver, ISO, and other styles
3

Role of Obesity in Cancer Survival and Recurrence: Workshop Summary. National Academies Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Klimo, Paul, and Nir Shimony. Ependymomas. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190696696.003.0026.

Full text
Abstract:
Pediatric posterior fossa tumors are usually ependymoma, pilocytic astrocytoma, or medulloblastoma. Ependymoma appears well-demarcated with heterogeneous enhancement on magnetic resonance imaging (MRI). Full neural axis MRI is indicated to assess for metastatic disease. Management is typically surgical resection of the tumor, with consideration for cerebrospinal fluid diversion if patients present with severe hydrocephalus. Extent of resection of the tumor is the most important factor in predicting recurrence and overall survival, and gross total resection is ideal. Infratentorial ependymomas
APA, Harvard, Vancouver, ISO, and other styles
5

Huntoon, Kristin, and J. Bradley Elder. High-Grade Gliomas. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190696696.003.0001.

Full text
Abstract:
Glioblastoma is the most common primary malignant brain tumor. This chapter discusses the clinical presentation and initial workup for a patient with a suspected glioblastoma, as well as the optimal treatment strategy and prognosis. Diagnosis is typically made using magnetic resonance imaging. Optimal treatment involves maximal safe surgical resection followed by adjuvant chemotherapy and radiation therapy. Surgical adjuncts including intraoperative imaging modalities and brain mapping techniques help improve neurologic morbidity associated with surgery. Despite maximal treatment, virtually al
APA, Harvard, Vancouver, ISO, and other styles
6

Ball, Steve, and Sajid Kalathil. Adrenocortical cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0094.

Full text
Abstract:
Adrenocortical cancer (ACC) is rare and associated with poor prognosis. The incidence is estimated at 0.7–2 cases per one million. Overall survival rate at five years for ACC is 37–47%. While the pathogenesis of ACC is incompletely understood, inherited predisposition syndromes are common in childhood ACC. Clinical presentation can be with symptoms and signs of hormone excess (functional tumours), mass effects, or as an incidental radiological finding. A multidisciplinary approach combining radiology, biochemistry, and tissue-based pathology is needed to establish a diagnosis to guide a surgic
APA, Harvard, Vancouver, ISO, and other styles
7

Schapira, Lidia, and Lauren Goldstein. Dealing with cancer recurrence. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198736134.003.0020.

Full text
Abstract:
When patients conclude active cancer therapy, many experience an elevated degree of awareness and worry about disease recurrence. For most patients, this anxiety is intermittent and tolerable, but for others, it is quite disruptive. Patients’ psychological and cognitive difficulties are not systematically explored during routine medical visits. Receiving the news of cancer recurrence is enormously difficult and so is the disclosure of news for the oncologist. The chapter provides practical tips for disclosing prognostic information. Physicians can and should pay particular attention to patient
APA, Harvard, Vancouver, ISO, and other styles
8

Vranckx, Pascal, Wilfried Mullens, and Johan Vijgen. Non-pharmacological therapy of acute heart failure: when drugs alone are not enough. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0053.

Full text
Abstract:
Acute heart failure syndrome has been defined as new-onset or a recurrence of worsening signs and symptoms of heart failure, necessitating urgent or emergency management. The management of acute heart failure syndrome is challenging, given the heterogeneity of the patient population, in terms of the clinical presentation, pathophysiology, prognosis, and therapeutic options. The management of acute heart failure syndrome is a dynamic process, requiring ongoing simultaneous diagnosis (monitoring) and treatment. Pharmacological agents remain the mainstay of therapy for acute heart failure syndrom
APA, Harvard, Vancouver, ISO, and other styles
9

Kissane, David W., Barry D. Bultz, Phyllis N. Butow, Carma L. Bylund, Simon Noble, and Susie Wilkinson, eds. Oxford Textbook of Communication in Oncology and Palliative Care. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198736134.001.0001.

Full text
Abstract:
This textbook integrates clinical wisdom with empirical findings, drawing upon the history of communication science, providing a comprehensive curriculum for applied communication skills training for specialist oncologists, surgeons, nurses, psychosocial care providers and other members of the multidisciplinary team. This new edition presents a curriculum for nurses, which discusses needs of pre-registration to advanced trainees, including the ‘SAGE &amp; THYME’ training programme, chronic disease, responding to depressed patients, the last hours and days of life, family care, facilitation tra
APA, Harvard, Vancouver, ISO, and other styles
10

Cui, Zhao, Neil Turner, and Ming-hui Zhao. Antiglomerular basement membrane disease. Edited by Neil Turner. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0073_update_001.

Full text
Abstract:
Cyclophosphamide and plasma exchange are the standard of care in rapidly progressive glomerulonephritis or lung haemorrhage caused by antiglomerular basement membrane (anti-GBM) disease, and it is unusual to encounter patients at earlier stages. Steroids are universally used in addition. There is some evidence that plasma exchange may not be a critical part of treatment at an earlier stage. There is no more than anecdotal evidence for other therapies. Slower-onset therapies such as antibodies to B cells are rarely appropriate. If untreated, patients with severe anti-GBM disease will not recove
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Prognosis e recurrence"

1

Shirota, Yukihiro, Taro Yamashita, Shuichi Terasaki, et al. "Treatment with Subsegmental Transcatheter Arterial Embolization for Hepatocellular Carcinoma: Prognosis, Recurrence, and Effect on Liver Function." In Progress in Hepatocellular Carcinoma Treatment. Springer Japan, 2000. http://dx.doi.org/10.1007/978-4-431-67913-4_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bashiri, Asher, and Jamie L. Borick. "Recurrent Pregnancy Loss: Definitions, Epidemiology, and Prognosis." In Recurrent Pregnancy Loss. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-27452-2_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Carp, Howard J. A. "How to Assess the Prognosis after Recurrent Miscarriage." In Recurrent Pregnancy Loss. John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118749012.ch5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Quinones, Addison, and Anne Le. "The Multifaceted Glioblastoma: From Genomic Alterations to Metabolic Adaptations." In The Heterogeneity of Cancer Metabolism. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_4.

Full text
Abstract:
AbstractGlioblastoma multiforme (GBM) develops on glial cells and is the most common as well as the deadliest form of brain cancer. As in other cancers, distinct combinations of genetic alterations in GBM subtypes induce a diversity of metabolic phenotypes, which explains the variability of GBM sensitivity to current therapies targeting its reprogrammed metabolism. Therefore, it is becoming imperative for cancer researchers to account for the temporal and spatial heterogeneity within this cancer type before making generalized conclusions about a particular treatment’s efficacy. Standard therapies for GBM have shown little success as the disease is almost always lethal; however, researchers are making progress and learning how to combine therapeutic strategies most effectively. GBMs can be classified initially into two subsets consisting of primary and secondary GBMs, and this categorization stems from cancer development. GBM is the highest grade of gliomas, which includes glioma I (low proliferative potential), glioma II (low proliferative potential with some capacity for infiltration and recurrence), glioma III (evidence of malignancy), and glioma IV (GBM) (malignant with features of necrosis and microvascular proliferation). Secondary GBM develops from a low-grade glioma to an advanced-stage cancer, while primary GBM provides no signs of progression and is identified as an advanced-stage glioma from the onset. The differences in prognosis and histology correlated with each classification are generally negligible, but the demographics of individuals affected and the accompanying genetic/metabolic properties show distinct differentiation [3].
APA, Harvard, Vancouver, ISO, and other styles
5

Hellers, Göran. "Prognostic factors for recurrence of Crohns disease." In Inflammatory Bowel Diseases 1986. Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-009-4269-1_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Anderson, Blaire, and Ryan C. Fields. "Prognosis and Management of Recurrent Metastatic Colorectal Cancer." In Colorectal Cancer Liver Metastases. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-25486-5_42.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Beyer, Jörg. "Prognostic Factors at Initial Presentation and in Recurrent Disease." In Diagnosis and Management of Testicular Cancer. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-17467-9_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mercy, Charles Solomon Akino, and Kalimuthusamy Natarajaseenivasan. "Prognosis and Impact of Recurrent Uveitis, the Ophthalmic Infection Caused by Leptospira spp." In Pocket Guide to Bacterial Infections. CRC Press, 2019. http://dx.doi.org/10.1201/b22196-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chiari, Mattia, Alfonso E. Gerevini, Matteo Olivato, Luca Putelli, Nicholas Rossetti, and Ivan Serina. "An Application of Recurrent Neural Networks for Estimating the Prognosis of COVID-19 Patients in Northern Italy." In Artificial Intelligence in Medicine. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-77211-6_36.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mah�, M. A., P. Romestaing, J. P. G�rard, et al. "Prognostic Factors for Local Control in Recurrent Cervical Carcinoma Treated with IORT: Report of the French IORT Group." In Frontiers of Radiation Therapy and Oncology. KARGER, 1997. http://dx.doi.org/10.1159/000061190.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Prognosis e recurrence"

1

Ouldamer, L. "EP944 Isolated lymph node recurrence in epithelial ovarian cancer: a recurrence with better prognosis?" In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.990.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Roshani, Faezeh, I. B. Turksen, M. H. Fazel Zarandi, and Maede Maftooni. "Fuzzy expert system for prognosis of breast cancer recurrence." In 2015 Annual Conference of the North American Fuzzy Information Processing Society (NAFIPS) held jointly with 2015 5th World Conference on Soft Computing (WConSC). IEEE, 2015. http://dx.doi.org/10.1109/nafips-wconsc.2015.7284208.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zhou, L., W. Yin, J. Lu, et al. "Time distributions and prognosis factors of breast cancer recurrence in different sites after operation." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-2080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Garg, Poonam. "Leiomyosarcoma: Case report." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685339.

Full text
Abstract:
Introduction: Uterine sarcomas are rare aggressive mesenchymal tumours with limited prognosis which accounts for only 2%-8% of all uterine malignancies. The most frequent type in uterine sarcomas is leiomyosarcoma (LMS) which is seen in about 60% of cases. Case Report: We report 2 cases who presentated with different symptomology. After examination and imaging modalities, definitive diagnosis was made after histopathology report. Treatment in the form of neo adjuvant chemotherapy followed by Surgery and chemotherapy/radiotherapy was given. On follow up, both patients had relapse and later they
APA, Harvard, Vancouver, ISO, and other styles
5

"Vulvar cancer: Patterns of recurrence and clinicopathological prognostic factors involved in recurrent cases." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685347.

Full text
Abstract:
Objective: Vulvar cancer is a rare disease, with an incidence of 0.6% of all female malignancies. With the advances in management of carcinoma vulva to individualisation of treatment to reduce the psychosexual impact an aggressive treatment can have, it is imperative to understand the patterns of recurrence and the common prognostic factors involved. The aim of this study was to determine prognostic variables for recurrence and survival and to identify patterns of recurrence in patients with vulvar cancer. Materials and Methods: All patients (n=87) with primary vulvar cancer treated at the Raj
APA, Harvard, Vancouver, ISO, and other styles
6

MORIHIRO, TOSHIAKI, Shinji Kuroda, Tetsushi Kubota, Hiroshi Tazawa, Shunsuke Kagawa, and Toshiyoshi Fujiwara. "Abstract 2649: PD-L1 expression as a predictive factor for recurrence pattern and prognosis in curatively resected gastric cancer." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2649.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Yang, Haojie, and Changpeng Han. "Abstract 2139: A seven lncRNA based risk score system for predicting the recurrence and prognosis of ovarian cancer patients." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-2139.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Muruzábal Torquemada, JC, C. Tauste Rubio, M. Visus, S. Aguirre Gorospe, and E. Villafranca Iturre. "EP737 Intraoperative Brachytherapy (HDR-IOBT) in advanced or recurrence gynecologic cancer: an effective alternative in tumors of poor prognosis." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.790.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rodrigues, Tatiane C., Felipe Carvalho, Ana C. V. Krepischi, Sergio Verjovski-Almeida, and Carla Rosenberg. "Abstract 1168: Identification of CNA signatures in prostate cancer: Narrowing chromosome regions related with occurrence, prognosis and recurrence after treatment." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-1168.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chacolla, RJ, VM Trevino, SP Scott, EA Guzman, and S. Cardona. "Abstract P4-09-04: Robust 7-gene signature for recurrence prognosis of breast cancer validated in formalin-fixed paraffin-embedded samples." In Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-p4-09-04.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Prognosis e recurrence"

1

Zhang, Fangfang, Lili Liu, Tian Li, and Zubing Mei. Prognostic value of metabolic syndrome for risk of stroke recurrence and mortality: A comprehensive systematic review with meta-analysis. INPLASY - International Platform of Registered Systematic Review Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.4.0183.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Prognosis e recurrence' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography